LSP BioVentures

2006

Founded

20

Investments

United States

Offices

Venture Fund

Investor Type

About

EQT Life Sciences, formerly known as LSP, is one of Europe's largest and most experienced healthcare investors, focusing on innovative life sciences and healthcare companies. With a track record spanning over 30 years, the firm has raised more than €3 billion and invested in over 150 private companies. The dedicated team comprises professionals with backgrounds in medicine, science, and industry, enabling them to identify and support groundbreaking innovations that can significantly impact patient care.

Their investment approach combines deep sector knowledge, analytical skills, and extensive experience to provide substantial value to entrepreneurs and companies.

Portfolio Companies

AM-Pharma, ActoGeniX (Intrexon), Aelin Therapeutics

Gepgraphic Focus

Europe

Key Differentiators

Extensive experience in healthcare investments, Dedicated team with diverse expertise, Focus on innovative solutions addressing unmet clinical needs

Thypical Investment Size

€10 million - €60 million

Total Funds Raised

€3 billion

Visit Website

Software

SaaS

Consumer

FinTech

Cambridge

Pre-Seed

Seed

Series A

Series B

Series C

Series D

United States